Taken together, five of the ovarian cancer cell lines studied (OVCA420, OVCA429, SKOV3, A2780s and A2780cp) acquire a functional TGF-β signalling pathway and are able to drive the transcriptional activation of p21WAF1/CIP1 on TGF-β treatment. This evidence concerns the gene TGFB1 and ovarian cancer.